AHA Statement on Decision by U.S. Supreme Court to Hear AHA Case on 340B Payment Cuts

Melinda Hatton
General Counsel
American Hospital Association

July 2, 2021

 
We are pleased that the U.S. Supreme Court has agreed to hear the compelling arguments in our case on payments cuts to the 340B drug pricing program that are adversely impacting care to patients. We are hopeful that the Court will reject the appellate court decision deferring to the government’s interpretation of the law that clearly imperils the important services that the 340B program helps allow eligible hospitals and health systems to provide to vulnerable communities, many of which would otherwise be unavailable.

###


Contact:        Colin Milligan, (202) 638-5491, cmilligan@aha.org

Marie Johnson, (202) 626-2351, mjohnson@aha.org

 

Related Resources

Special Bulletin
Public
President Biden today submitted to Congress his budget request for fiscal year (FY) 2023.
Testimony
Public
AHA shares proposals to lower Medicare drug prices with congress.
Special Bulletin
Public
The Senate last night passed a $1.5 trillion omnibus appropriations bill that would fund the federal government through the end of the current fiscal year.
Special Bulletin
Public
The House of Representatives last night passed a $1.5 trillion omnibus appropriations bill that would fund the federal government through the end of the…
Special Bulletin
Public
The House Appropriations Committee announced an agreement on omnibus appropriations legislation funding the federal government through the end of the current…
Letter/Comment
Public
AHA urges HHS to ensure hospitals participating in the 340B Drug Pricing Program do not lose access to the program as a result of changes in patterns of…